COMMUNIQUÉS West-GlobeNewswire

OPKO Health to Announce Fourth Quarter 2018 Financial Results on February 27, 2019

26/02/2019 - 14:00

MIAMI, Feb. 26, 2019 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (NASDAQ: OPK) plans to announce its operating and financial results for the three and twelve months ended December 31, 2018 as well as provide guidance on [...]

Centura Health Joins Innovative Movement for One-Stick Hospitalization

26/02/2019 - 14:00

Partners with Fast Company’s Most Innovative Company recipient, Velano Vascular, to deliver PIVO to inpatients in Colorado and Kansas ENGLEWOOD, Colo., Feb. 26, 2019 (GLOBE NEWSWIRE) -- Centura Health, the region’s [...]

Philips introduces IntelliSpace Portal 11 at ECR 2019 to support diagnostic confidence

26/02/2019 - 14:00

February 26, 2019 Latest release of Philips advanced visualization platform continues to build on innovations in intelligent clinical applications, hospital network connectivity, and patient data security Amsterdam, the [...]

Dermira to Present New Analyses of the Glycopyrronium Tosylate Clinical Program at the 77th American Academy of Dermatology Annual Meeting

26/02/2019 - 14:00

MENLO PARK, Calif., Feb. 26, 2019 (GLOBE NEWSWIRE) -- Dermira, Inc. (NASDAQ: DERM), a biopharmaceutical company dedicated to bringing biotech ingenuity to medical dermatology by delivering differentiated, new therapies [...]

CareDx to Participate in the Cowen and Company 39th Annual Health Care Conference

26/02/2019 - 14:00

BRISBANE, Calif., Feb. 26, 2019 (GLOBE NEWSWIRE) -- CareDx, Inc. (Nasdaq: CDNA), a molecular diagnostics company focused on the discovery, development and commercialization of clinically differentiated, high-value [...]

Inhibikase Therapeutics Files Two Investigational New Drug Applications for IkT-148009, a Disease-Modifying Therapy for Parkinson’s Disease

26/02/2019 - 14:00

ATLANTA and BOSTON, Feb. 26, 2019 (GLOBE NEWSWIRE) -- Inhibikase Therapeutics, Inc., a pharmaceutical company developing protein kinase inhibitors for treatment of neurological infections and neurodegenerative diseases [...]

BioTime to Present New Data From OpRegen® and Vision Restoration Programs at the Association for Research in Vision and Ophthalmology Annual Meeting (ARVO 2019)

26/02/2019 - 14:00

ALAMEDA, Calif., Feb. 26, 2019 (GLOBE NEWSWIRE) -- BioTime, Inc. (NYSE American: BTX), a clinical-stage biotechnology company focused on degenerative diseases, announced today that updated results from a Phase I/IIa [...]

electroCore Announces Positive Coverage Policies of gammaCore Issued by Highmark

26/02/2019 - 14:00

BASKING RIDGE, N.J., Feb. 26, 2019 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine company, today announced that Highmark, one of the nation’s top health insurers and the [...]

Foamix -- with Late-Stage Candidates in Acne and Rosacea -- to Participate at American Academy of Dermatology Annual Meeting

26/02/2019 - 14:00

REHOVOT, Israel and BRIDGEWATER, N.J., Feb. 26, 2019 (GLOBE NEWSWIRE) -- Foamix Pharmaceuticals Ltd. (NASDAQ:FOMX) (“Foamix” or the “Company”), a clinical stage specialty pharmaceutical company focused on developing and [...]

Spero Therapeutics Receives QIDP Designation from the U.S. FDA for the Development of SPR720

26/02/2019 - 14:00

Phase 1 top-line data readout for oral SPR720 expected in second half of 2019 CAMBRIDGE, Mass., Feb. 26, 2019 (GLOBE NEWSWIRE) -- Spero Therapeutics, Inc. (Nasdaq:SPRO), a multi-asset clinical-stage biopharmaceutical [...]

Ceapro Inc. Announces Three Abstracts Selected for Oral Presentation at the 17th European Meeting on Supercritical Fluids (EMSF 2019)

26/02/2019 - 14:00

- Important research findings from collaboration with University of Alberta demonstrating potential of Ceapro’s unique enabling PGX technology to produce innovative delivery systems - EDMONTON, Alberta, Feb. 26, 2019 ( [...]

Chimerix to Announce Fourth Quarter and Full Year 2018 Financial Results on March 5, 2019

26/02/2019 - 14:00

DURHAM, N.C., Feb. 26, 2019 (GLOBE NEWSWIRE) -- Chimerix, Inc. (Nasdaq: CMRX), a biopharmaceutical company developing novel antivirals to address life-threatening viral infections, today announced that it will host a [...]

Q BioMed's Autism Spectrum Disorder Drug Development Program Featured in February Issue of Leading Pharma/Biotech Newspaper

26/02/2019 - 14:00

Groundbreaking pediatric non-verbal disorder treatment QBM-001 presented to over 30,000 drug discovery professionals through print edition of DDN News NEW YORK, Feb. 26, 2019 (GLOBE NEWSWIRE) -- Q BioMed Inc. ( QBIO ), [...]

BioSig Announces Expansion of Engineering Team

26/02/2019 - 13:52

New hires to drive R&D and manufacturing efforts Santa Monica, CA, Feb. 26, 2019 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (NASDAQ: BSGM), a medical device company developing a proprietary biomedical signal [...]

Transactions in relation to share buyback program

26/02/2019 - 13:40

Acting under its share buyback authorization, the GN Store Nord Board of Directors initiated a share buyback program on May 2, 2018, in accordance with article 5 of the regulation (EU) no. 596/2014 of 16 April 2014 on [...]

Ocutrx Vision Technologies dévoile le concept révolutionnaire Oculenz AR à connectivité cellulaire avec le design des lunettes de poursuite oculaire

26/02/2019 - 13:36

La nouvelle conception esthétique offre une technologie et des fonctionnalités sans précédent dans l'industrie AR Wear BARCELONE, Espagne, 26 févr. 2019 (GLOBE NEWSWIRE) -- Ocutrx Vision Technologies, LLC , fabricant de [...]

How Augmented Reality is Transforming the Fashion Industry -- CFN Media

26/02/2019 - 13:30

SEATTLE, Feb. 26, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- CFN Media Group (“CFN Media”), the leading agency and financial media network dedicated to the North American cannabis industry, announces publication of an [...]

FSD Pharma's Investments in Cutting-Edge Tech Could Pay Big Dividends -- CFN Media

26/02/2019 - 13:30

SEATTLE, Feb. 26, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- CFN Media Group (“CFN Media”), the leading agency and financial media network dedicated to the North American cannabis industry, announces publication of an [...]

New data shows ALK’s house dust mite SLIT-tablet significantly improves quality of sleep for allergic rhinitis patients

26/02/2019 - 09:03

Approximately 9 out of 10 trial subjects with 'moderately or severely affected sleep' saw an improvement following treatment with ALK’s HDM SLIT-tablet. The results were revealed by a post-hoc analysis of sleep-specific [...]